Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Here, we study the intricate relationship between gut microbiota and host cometabolic phenotypes associated with dietary-induced impaired glucose homeostasis and nonalcoholic fatty liver disease (NAFLD) in a mouse strain (129S6) known to be susceptible to these disease traits, using plasma and urine metabotyping, achieved by (1)H NMR spectroscopy. Multivariate statistical modeling of the spectra shows that the genetic predisposition of the 129S6 mouse to impaired glucose homeostasis and NAFLD is associated with disruptions of choline metabolism, i.e., low circulating levels of plasma phosphatidylcholine and high urinary excretion of methylamines (dimethylamine, trimethylamine, and trimethylamine-N-oxide), coprocessed by symbiotic gut microbiota and mammalian enzyme systems. Conversion of choline into methylamines by microbiota in strain 129S6 on a high-fat diet reduces the bioavailability of choline and mimics the effect of choline-deficient diets, causing NAFLD. These data also indicate that gut microbiota may play an active role in the development of insulin resistance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A causal role for the involvement of gut microbes is in part based on the fulfillment of one of Koch’s postulates - namely, the transmission of a disease related phenotype with transplantation of gut microbial organisms to a new host (Cho and Blaser, 2012; Cox et al., 2014; Dumas et al., 2006; Gregory et al., 2015; Koch, 1880; Sandhu and Chase, 1986).”
From Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis (2015) · cites this paper as Dumas et al., 2006
In the citing paper
“Interestingly, dysbiotic microbiota from mice fed a high-fat diet metabolize and convert dietary choline into methylamines, resulting in low circulating levels of plasma phosphatidylcholine60.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [60]
In the citing paper
“Serum and urinary concentrations of methylamines including TMAO were associated with the development of nonalcoholic fatty liver and impairment of glucose metabolism in high-fat-fed 129S6 mice (39).”
From Trimethylamine N -Oxide, the Microbiome, and Heart and Kidney Disease (2017) · cites this paper as [39]
In the citing paper
“It has been demonstrated that the gut microbiota can play a role in the development of metabolic abnormalities such as insulin resistance and nonalcoholic fatty liver disease76,77.”
From Dietary metabolism, the gut microbiome, and heart failure (2019) · cites this paper as [77]
Citations
Cites
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277
Metagenomic Analysis of the Human Distal Gut Microbiome
Gill, S. R., Pop, M., DeBoy, R. T., Eckburg, P. B., Turnbaugh, P. J., Samuel, B. S., Gordon, J. I., Relman, D. A., Fraser-Liggett, C. M., & Nelson, K. E. (2006) · Science · doi:10.1126/science.1124234 · Cited by 4,699
Nicholson, J. K., Lindon, J. C., & Holmes, E. (1999) · Xenobiotica · doi:10.1080/004982599238047 · Cited by 3,895
Self-citationMetabonomics: a platform for studying drug toxicity and gene function
Nicholson, J. K., Connelly, J., Lindon, J. C., & Holmes, E. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd728 · Cited by 1,914
Self-citation
Research works printed but not linked: 2
- A. L. Buchman, M. D. Dubin, A. A. Moukarzel, D. J. Jenden, M. Roch, K. M. Rice, J. Gornbein, M. E. Ament Hepatology 22, 1399–1403 (1995).
- S. H. Zeisel, J. S. Wishnok, J. K. Blusztajn J. Pharmacol. Exp. Ther. 225, 320–324 (1983).
Cited by
Items 101–200 of 942
Schwimmer, J. B., Johnson, J. S., Angeles, J. E., Behling, C., Belt, P. H., Borecki, I., Bross, C., Durelle, J., Goyal, N. P., Hamilton, G., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.06.028 · Cited by 298
Org, E., Blum, Y., Kasela, S., Mehrabian, M., Kuusisto, J., Kangas, A. J., Soininen, P., Wang, Z., Ala-Korpela, M., Hazen, S. L., et al. (2017) · Genome Biology · doi:10.1186/s13059-017-1194-2 · Cited by 331
Gut microbiome and its role in obesity and insulin resistance
Lee, C. J., Sears, C. L., & Maruthur, N. (2020) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14107 · Cited by 350
The Human Intestinal Microbiome: A New Frontier of Human Biology
Hattori, M., & Taylor, T. D. (2009) · DNA Research · doi:10.1093/dnares/dsn033 · Cited by 281
Microbes in Gastrointestinal Health and Disease
Neish, A. S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.080 · Cited by 1,386
Role of melatonin in sleep deprivation‐induced intestinal barrier dysfunction in mice
Gao, T., Wang, Z., Dong, Y., Cao, J., Lin, R., Wang, X., Yu, Z., & Chen, Y. (2019) · Journal of Pineal Research · doi:10.1111/jpi.12574 · Cited by 292
Vallianou, N., Christodoulatos, G. S., Karampela, I., Tsilingiris, D., Magkos, F., Stratigou, T., Kounatidis, D., & Dalamaga, M. (2021) · Biomolecules · doi:10.3390/biom12010056 · Cited by 289
Defining the Metabolome: Size, Flux, and Regulation
Zamboni, N., Saghatelian, A., & Patti, G. J. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.04.021 · Cited by 300
“This is best exemplified in the study by Fan et al. (Fan et al., 2014), in which numerous experiments with 2H, 13C, and 14C tracers and local and quantitative analyses were assembled into a cell-wide and yet accurate picture of NADPH metabolism.”
BackgroundDietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats
Cani, P. D., Hoste, S., Guiot, Y., & Delzenne, N. M. (2007) · British Journal of Nutrition · doi:10.1017/s0007114507691648 · Cited by 274
“The present results fit with the idea that events occurring in the colon (fermentation; modulation of gut microbiota) exert a key influence on the overall host metabolism (Backhed et al. 2004; Dumas et al. 2006).”
ResultNyangale, E. P., Mottram, D. S., & Gibson, G. R. (2012) · Journal of Proteome Research · doi:10.1021/pr300637d · Cited by 268
Nutritional Metabonomics: Applications and Perspectives
Rezzi, S., Ramadan, Z., Fay, L. B., & Kochhar, S. (2007) · Journal of Proteome Research · doi:10.1021/pr060522z · Cited by 269
Human gut microbiota: the links with dementia development
Alkasir, R., Li, J., Li, X., Jin, M., & Zhu, B. (2017) · Protein & Cell · doi:10.1007/s13238-016-0338-6 · Cited by 285
“Metabolomics study by Dumas et al suggested that gut microbiota may also play an active role in the development of complex metabolic abnormalities, such as susceptibility to insulin resistance and fatty liver disease (Dumas et al., 2006).”
BackgroundThe gut microbiota drives the impact of bile acids and fat source in diet on mouse metabolism
Just, S., Mondot, S., Ecker, J., Wegner, K., Rath, E., Gau, L., Streidl, T., Hery-Arnaud, G., Schmidt, S., Lesker, T. R., et al. (2018) · Microbiome · doi:10.1186/s40168-018-0510-8 · Cited by 269
Top-Down Systems Biology Modeling of Host Metabotype−Microbiome Associations in Obese Rodents
Waldram, A., Holmes, E., Wang, Y., Rantalainen, M., Wilson, I. D., Tuohy, K. M., McCartney, A. L., Gibson, G. R., & Nicholson, J. K. (2009) · Journal of Proteome Research · doi:10.1021/pr8009885 · Cited by 264
Self-citationDonohoe, D. R., & Bultman, S. J. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.24054 · Cited by 295
“bodies including those involved in choline metabolism (and therefore possibly CpG methylation) (Dumas et al., 2006; Li et al., 2008; Wikoff et al., 2009).”
BackgroundIs the Gut Microbiota a New Factor Contributing to Obesity and Its Metabolic Disorders?
Harris, K., Kassis, A., Major, G., & Chou, C. J. (2012) · Journal of Obesity · doi:10.1155/2012/879151 · Cited by 276
“Conv mice fed high-fat diets had higher conversion of choline to methylamines as compared to those on low-fat diets [107].”
BackgroundGut microbiota and diabetes: from pathogenesis to therapeutic perspective
Burcelin, R., Serino, M., Chabo, C., Blasco-Baque, V., & Amar, J. (2011) · Acta Diabetologica · doi:10.1007/s00592-011-0333-6 · Cited by 257
Obesity in Type 1 Diabetes: Pathophysiology, Clinical Impact, and Mechanisms
Corbin, K. D., Driscoll, K. A., Pratley, R. E., Smith, S. R., Maahs, D. M., Mayer-Davis, E. J., & Advancing Care for Type 1 Diabetes and Obesity Network (ACT1ON) (2018) · Endocrine Reviews · doi:10.1210/er.2017-00191 · Cited by 262
Hocking, S., Samocha-Bonet, D., Milner, K.-L., Greenfield, J. R., & Chisholm, D. J. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1041 · Cited by 276
Intersections Between Microbiome and Heart Failure: Revisiting the Gut Hypothesis
Nagatomo, Y., & Tang, W. H. W. (2015) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2015.09.017 · Cited by 259
“Experiments in fecal transplantation from conventionally-raised animals to germ-free or microbiota-ablated ones have shown that these lifestyle alterations contribute, at least in part, to the pathogenesis of these diseases [7-11].”
BackgroundBae, S., Ulrich, C. M., Neuhouser, M. L., Malysheva, O., Bailey, L. B., Xiao, L., Brown, E. C., Cushing-Haugen, K. L., Zheng, Y., Cheng, T.-Y. D., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1835 · Cited by 253
Endoplasmic reticulum stress and lipids in health and diseases
Celik, C., Lee, S. Y. T., Yap, W. S., & Thibault, G. (2023) · Progress in Lipid Research · doi:10.1016/j.plipres.2022.101198 · Cited by 262
Conterno, L., Fava, F., Viola, R., & Tuohy, K. M. (2011) · Genes & Nutrition · doi:10.1007/s12263-011-0230-1 · Cited by 247
“Dumas et al. (2006) studied the crosstalk between mammalian and microbiotal metabolism in dietary-induced impaired glucose homeostasis and non-alcoholic fatty liver disease (NAFLD) in the 129S6 mouse model.”
BackgroundGut microbial metabolites in depression: understanding the biochemical mechanisms
Caspani, G., Kennedy, S., Foster, J. A., & Swann, J. (2019) · Microbial Cell · doi:10.15698/mic2019.10.693 · Cited by 284
The gut microbiota: A treasure for human health
Li, D., Wang, P., Wang, P., Hu, X., & Chen, F. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.08.003 · Cited by 261
Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
Lee, K.-C., Wu, P.-S., & Lin, H.-C. (2023) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0237 · Cited by 246
Gut microbiota and non-alcoholic fatty liver disease: new insights
Aron-Wisnewsky, J., Gaborit, B., Dutour, A., & Clement, K. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12140 · Cited by 248
“NASH both by decreasing choline levels and increasing toxic methylamines [123,124].”
BackgroundTrimethylamine-N-oxide (TMAO) as Novel Potential Biomarker of Early Predictors of Metabolic Syndrome
Barrea, L., Annunziata, G., Muscogiuri, G., Di Somma, C., Laudisio, D., Maisto, M., De Alteriis, G., Tenore, G. C., Colao, A., & Savastano, S. (2018) · Nutrients · doi:10.3390/nu10121971 · Cited by 257
“NAFLD Experimental study Mouse strain 129S6, documented for its susceptibility to IR or NAFLD Mice 129S6 fed with a high-fat diet showed a high urinary excretion of TMAO associated with insulin resistance and NAFLD A high-fat diet reduces the conversion and the bioavailability of choline by microbiota, causing NAFLD […”
BackgroundMetabolic Perturbance in Autism Spectrum Disorders: A Metabolomics Study
Ming, X., Stein, T. P., Barnes, V., Rhodes, N., & Guo, L. (2012) · Journal of Proteome Research · doi:10.1021/pr300910n · Cited by 234
Epigenetic mechanisms elicited by nutrition in early life
Canani, R. B., Di Costanzo, M., Leone, L., Bedogni, G., Brambilla, P., Cianfarani, S., Nobili, V., Pietrobelli, A., & Agostoni, C. (2011) · Nutrition Research Reviews · doi:10.1017/s0954422411000102 · Cited by 228
Zhang, M., Sun, Y., Chen, K., Yu, N., Zhou, Z., Chen, L., Du, Z., & Li, E. (2014) · Aquaculture · doi:10.1016/j.aquaculture.2014.09.008 · Cited by 230
Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity
Beger, R. D., Sun, J., & Schnackenberg, L. K. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.11.019 · Cited by 216
Martínez-del Campo, A., Bodea, S., Hamer, H. A., Marks, J. A., Haiser, H. J., Turnbaugh, P. J., & Balskus, E. P. (2015) · mBio · doi:10.1128/mbio.00042-15 · Cited by 224
“Nonalcoholic fatty liver disease, a known consequence of choline deficiency, may be exacerbated by excess microbial choline metabolism (21).”
BackgroundNonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity?
Aron-Wisnewsky, J., Warmbrunn, M. V., Nieuwdorp, M., & Clément, K. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.01.049 · Cited by 239
Emwas, A.-H., Luchinat, C., Turano, P., Tenori, L., Roy, R., Salek, R. M., Ryan, D., Merzaban, J. S., Kaddurah-Daouk, R., Zeri, A. C., et al. (2015) · Metabolomics · doi:10.1007/s11306-014-0746-7 · Cited by 238
“Since the outcomes of treatment interventions are influenced by an individual’s metabolic phenotype for which the gut status is a determining factor (Dumas et al. 2006), it has been proposed that gut microorganisms should be considered as part of personalized treatment solutions (Holmes et al.…”
BackgroundPancreatic Ectopic Fat Is Characterized by Adipocyte Infiltration and Altered Lipid Composition
Pinnick, K. E., Collins, S. C., Londos, C., Gauguier, D., Clark, A., & Fielding, B. A. (2008) · Obesity · doi:10.1038/oby.2007.110 · Cited by 226
“For this dietary study, we used a HFD as described previously (27).”
MethodSelf-citationGut microbiota: next frontier in understanding human health and development of biotherapeutics
Prakash, S., Rodes, L., Coussa-Charley, M., Tomaro-Duchesneau, C., Tomaro-Duchesneau, C., Coussa-Charley, & Rodes (2011) · Biologics: Targets and Therapy · doi:10.2147/btt.s19099 · Cited by 256
“Finally, the microbiota may affect insulin resistance and steatosis by regulating choline metabolism.(92) Thus, alteration of the gut microbiota causes defective energy and lipid metabolism leading to the development of metabolic disease (Figure 4).”
Ametaj, B. N., Zebeli, Q., Saleem, F., Psychogios, N., Lewis, M. J., Dunn, S. M., Xia, J., & Wishart, D. S. (2010) · Metabolomics · doi:10.1007/s11306-010-0227-6 · Cited by 211
“These studies allow one to explore the symbiotic complexity between the host and its microbiota as affected by diet, and to unravel the effects of diet on the development of metabolic diseases (Dumas et al. 2006).”
BackgroundBeyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis†
Maher, J. J., Leon, P., & Ryan, J. C. (2008) · Hepatology · doi:10.1002/hep.22399 · Cited by 203
NAFLD, Insulin Resistance, and Diabetes Mellitus Type 2
Marušić, M., Paić, M., Knobloch, M., & Liberati Pršo, A.-M. (2021) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2021/6613827 · Cited by 230
Goldsmith, J. R., & Sartor, R. B. (2014) · Journal of Gastroenterology · doi:10.1007/s00535-014-0953-z · Cited by 214
“a metabolite (choline) with health consequences for the host [69].”
BackgroundMetabolic retroconversion of trimethylamine N-oxide and the gut microbiotaPreprint
Hoyles, L., Jiménez-Pranteda, M. L., Chilloux, J., Brial, F., Myridakis, A., Aranias, T., Magnan, C., Gibson, G., Sanderson, J., Nicholson, J., et al. (2018) · Microbiome · doi:10.1101/225581 · Cited by 211
Self-citationA review of metabolic potential of human gut microbiome in human nutrition
Yadav, M., Verma, M. K., & Chauhan, N. S. (2018) · Archives of Microbiology · doi:10.1007/s00203-017-1459-x · Cited by 290
“Lack of choline in the diet has a direct effect on gut microbes and can cause liver steatosis in mice as well as humans (Dumas et al. 2006; Spencer et al. 2011).”
BackgroundLeaky gut and the liver: A role for bacterial translocation in nonalcoholic steatohepatitis
Ilan, Y. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i21.2609 · Cited by 196
Metabolomics in Toxicology: Preclinical and Clinical Applications
Robertson, D. G., Watkins, P. B., & Reily, M. D. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfq358 · Cited by 211
“The above examples highlight that a key area of metabolomic research over the past 10 years has been with regard to the role gut microflora plays with systemic biochemistry (Calvani et al., 2010; Dumas et al., 2006; Fava et al., 2006; Martin et al., 2007; Nicholson, 2008; Nicholson and Wilson, 2003; Nicholson et al.,…”
BackgroundDelzenne, N. M., Cani, P. D., & Neyrinck, A. M. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.11.2547s · Cited by 207
“Other authors have shown that events occurring in the colon (fermentation; modulation of gut microbiota) exert a key influence on the overall host metabolism by modulating peptides such as fasting-induced adiposetissue factor (38,39).”
Yin, P., Wan, D., Zhao, C., Chen, J., Zhao, X., Wang, W., Lu, X., Yang, S., Gu, J., & Xu, G. (2009) · Molecular BioSystems · doi:10.1039/b820224a · Cited by 225
Urinary metabolic signatures of human adiposity
Elliott, P., Posma, J. M., Chan, Q., Garcia-Perez, I., Wijeyesekera, A., Bictash, M., D. Ebbels, T. M., Ueshima, H., Zhao, L., van Horn, L., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa5680 · Cited by 207
Self-citationWall, R., Ross, R. P., Shanahan, F., O’Mahony, L., O’Mahony, C., Coakley, M., Hart, O., Lawlor, P., Quigley, E. M., Kiely, B., et al. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.27023 · Cited by 199
“The microbiota is a regulator of fat storage (9) and a contributor to a fatty liver phenotype in insulin-resistant mice (10).”
BackgroundSystematic review: microbial dysbiosis and nonalcoholic fatty liver disease
Wieland, A., Frank, D. N., Harnke, B., & Bambha, K. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13376 · Cited by 207
“choline-deficient diet by decreasing effective choline levels and exposes the host to an inflammatory toxic metabolite.(66) Spen-”
Microbiota and Gut–Liver Axis: Their Influences on Obesity and Obesity‐Related Liver Disease
Vajro, P., Paolella, G., & Fasano, A. (2013) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e318284abb5 · Cited by 201
“Dumas et al (29) have recently shown in a NAFLD-susceptible insulin-resistant mouse model that gut microbiota may mimic choline-deficient diets.”
BackgroundYu, J., Marsh, S., Hu, J., Feng, W., & Wu, C. (2016) · Gastroenterology Research and Practice · doi:10.1155/2016/2862173 · Cited by 199
“Recent studies indicate a role of the intestinal microbiota in the conversion of dietary choline to toxic methylamine, a substance that not only mimics a cholinedeficient diet by decreasing effective choline levels but also exposes the host to an inflammatory toxic metabolite [75].”
BackgroundDitano-Vázquez, P., Torres-Peña, J. D., Galeano-Valle, F., Pérez-Caballero, A. I., Demelo-Rodríguez, P., Lopez-Miranda, J., Katsiki, N., Delgado-Lista, J., & Alvarez-Sala-Walther, L. A. (2019) · Nutrients · doi:10.3390/nu11112833 · Cited by 235
Jiang, T., Gao, X., Wu, C., Tian, F., Lei, Q., Bi, J., Xie, B., Wang, H., Chen, S., & Wang, X. (2016) · Nutrients · doi:10.3390/nu8030126 · Cited by 220
Shortt, C., Hasselwander, O., Meynier, A., Nauta, A., Fernández, E. N., Putz, P., Rowland, I., Swann, J., Türk, J., Vermeiren, J., et al. (2018) · European Journal of Nutrition · doi:10.1007/s00394-017-1546-4 · Cited by 194
“Moreover, differences were in lipid metabolism were observed when two strains of mice (129S6 and BALBc) were fed with diets providing either 5 or 40% of fat (consisting of 40% lard and 8% corn oil) for a 4 month period [41].”
Trimethylamine- N -Oxide: Friend, Foe, or Simply Caught in the Cross-Fire?
Cho, C. E., & Caudill, M. A. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2016.10.005 · Cited by 218
“Gut Microbiome Several disease states are now being linked with pathological variation in the gut microbiome, and data from rodent studies suggest that dysbiosis contributes to disease pathogenesis [54,55].”
BackgroundZhou, S.-S., Xu, J., Zhu, H., Wu, J., Xu, J.-D., Yan, R., Li, X.-Y., Liu, H.-H., Duan, S.-M., Wang, Z., et al. (2016) · Scientific Reports · doi:10.1038/srep22474 · Cited by 185
Sanchez-Rodriguez, E., Egea-Zorrilla, A., Plaza-Díaz, J., Aragón-Vela, J., Muñoz-Quezada, S., Tercedor-Sánchez, L., & Abadia-Molina, F. (2020) · Nutrients · doi:10.3390/nu12030605 · Cited by 214
Torres, N., Guevara-Cruz, M., Velázquez-Villegas, L. A., & Tovar, A. R. (2015) · Archives of Medical Research · doi:10.1016/j.arcmed.2015.05.010 · Cited by 273
Metabolomics Applied to Diabetes Research
Bain, J. R., Stevens, R. D., Wenner, B. R., Ilkayeva, O., Muoio, D. M., & Newgard, C. B. (2009) · Diabetes · doi:10.2337/db09-0580 · Cited by 328
“An intriguing and more promising recent application of (1)H NMR–based metabolic analysis has been to study the influence of intestinal bacteria (microbiota) on development of obesity and metabolic diseases (80).”
BackgroundZhang, Y., Chen, R., Zhang, D., Qi, S., & Liu, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114295 · Cited by 198
Intestinal Barrier and Permeability in Health, Obesity and NAFLD
Portincasa, P., Bonfrate, L., Khalil, M., Angelis, M. D., Calabrese, F. M., D’Amato, M., Wang, D. Q.-H., & Di Ciaula, A. (2021) · Biomedicines · doi:10.3390/biomedicines10010083 · Cited by 211
Chen, C., Shah, Y. M., Morimura, K., Krausz, K. W., Miyazaki, M., Richardson, T. A., Morgan, E. T., Ntambi, J. M., Idle, J. R., & Gonzalez, F. J. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.12.003 · Cited by 167
“…of metabolomics, possesses the capacity to detect subtle changes in a large data set, the potential application of metabolomics in the diagnosis of disease (Brindle et al., 2002) and the characterization of disease-related animal models (Dumas et al., 2006; Jones et al., 2005) has been explored.”
BackgroundAlteration of bile acid metabolism in the rat induced by chronic ethanol consumption
Xie, G., Zhong, W., Li, H., Li, Q., Qiu, Y., Zheng, X., Chen, H., Zhao, X., Zhang, S., Zhou, Z., et al. (2013) · The FASEB Journal · doi:10.1096/fj.13-231860 · Cited by 193
Gut Microbiota, Host Organism, and Diet Trialogue in Diabetes and Obesity
Lazar, V., Ditu, L.-M., Pircalabioru, G. G., Picu, A., Petcu, L., Cucu, N., & Chifiriuc, M. C. (2019) · Frontiers in Nutrition · doi:10.3389/fnut.2019.00021 · Cited by 210
Obesity, fatty liver disease and intestinal microbiota
Arslan, N. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i44.16452 · Cited by 190
Shanab, A. A., Scully, P., Crosbie, O., Buckley, M., O’Mahony, L., Shanahan, F., Gazareen, S., Murphy, E., & Quigley, E. M. M. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1447-3 · Cited by 188
“Alcoholic and nonalcoholic liver diseases share common pathological features and both conditions have been associated with intestinal endotoxaemia [25–28].”
BackgroundSherriff, J. L., O'Sullivan, T. A., Properzi, C., Oddo, J.-L., & Adams, L. A. (2016) · Advances in Nutrition · doi:10.3945/an.114.007955 · Cited by 189
“This suggests reduced bioavailability of dietary choline, and increased urinary methylamines indicate increased bacterial metabolism of choline by the gut (54).”
BackgroundHeianza, Y., Sun, D., Li, X., DiDonato, J. A., Bray, G. A., Sacks, F. M., & Qi, L. (2019) · Gut · doi:10.1136/gutjnl-2018-316155 · Cited by 177
Gut Microbiome and Obesity: A Plausible Explanation for Obesity
Sanmiguel, C., Gupta, A., & Mayer, E. A. (2015) · Current Obesity Reports · doi:10.1007/s13679-015-0152-0 · Cited by 204
Canyelles, M., Tondo, M., Cedó, L., Farràs, M., Escolà-Gil, J. C., & Blanco-Vaca, F. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103228 · Cited by 188
Dumas, M., Kinross, J., & Nicholson, J. K. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.11.001 · Cited by 187
Self-citationZhuang, R., Ge, X., Han, L., Yu, P., Gong, X., Meng, Q., Zhang, Y., Fan, H., Zheng, L., Liu, Z., et al. (2019) · Obesity Reviews · doi:10.1111/obr.12843 · Cited by 179
“(2) Dietary TMAO may have deteriorated impaired glucose tolerance, obstructed hepatic insulin signal transduction, and caused adipose tissue inflammation in mice fed with the high‐fat diet.(5,9) Insulin resistance and the corresponding upregulation of insulin levels contributed to FMO3 activity and the increase in TMA…”
BackgroundThe Biological Role of Inflammation in Atherosclerosis
Wong, B. W., Meredith, A., Lin, D., & McManus, B. M. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.06.023 · Cited by 168
Gallic Acid Ameliorated Impaired Glucose and Lipid Homeostasis in High Fat Diet-Induced NAFLD Mice
Chao, J., Huo, T.-I., Cheng, H.-Y., Tsai, J.-C., Liao, J.-W., Lee, M.-S., Qin, X.-M., Hsieh, M.-T., Pao, L.-H., & Peng, W.-H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096969 · Cited by 168
“On other hand, when the HFD and GA treatment groups were compared, the HFD group mice were found to have higher levels of methylamine-associated metabolites (Table 2 and Table 3), which suggests that GA is able to reduce the elevation in gut microflora choline metabolism present in HFD fed mice to a similar level to t…”
BackgroundInfluentialPathophysiology of NASH: perspectives for a targeted treatment
Marra, F., & Lotersztajn, S. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990344 · Cited by 163
“In fact, studies in mice and humans have demonstrated that gut bacteria contribute to determine the susceptibility to develop fatty liver, partly through modifications in choline metabolism [96, 97].”
Bu, Q., Yan, G., Deng, P., Peng, F., Lin, H., Xu, Y., Cao, Z., Zhou, T., Xue, A., Wang, Y., et al. (2010) · Nanotechnology · doi:10.1088/0957-4484/21/12/125105 · Cited by 177
Implication of gut microbiota metabolites in cardiovascular and metabolic diseases
Brial, F., Le Lay, A., Dumas, M.-E., & Gauguier, D. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2901-1 · Cited by 198
Self-citationExpanding role of gut microbiota in lipid metabolism
Ghazalpour, A., Cespedes, I., Bennett, B. J., & Allayee, H. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000278 · Cited by 172
Lin, H., An, Y., Hao, F., Wang, Y., & Tang, H. (2016) · Scientific Reports · doi:10.1038/srep21618 · Cited by 172
Kijmanawat, A., Panburana, P., Reutrakul, S., & Tangshewinsirikul, C. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.12863 · Cited by 174
Integration of microbiome and epigenome to decipher the pathogenesis of autoimmune diseases
Chen, B., Sun, L., & Zhang, X. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.03.009 · Cited by 166
“For example, folate and choline were reported both to be methyl donors [107,108], which played a significant role in DNA and histone methylations.”
BackgroundHrncir, T., Hrncirova, L., Kverka, M., Hromadka, R., Machova, V., Trckova, E., Kostovcikova, K., Kralickova, P., Krejsek, J., & Tlaskalova-Hogenova, H. (2021) · Microorganisms · doi:10.3390/microorganisms9050957 · Cited by 174
“Firstly, it decreases choline liver bioavailability, which leads to the inefficient export of VLDL particles out of the liver, lipid accumulation, and liver inflammation [89].”
BackgroundSharpton, S. R., Ajmera, V., & Loomba, R. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.08.065 · Cited by 169
“A high-fat diet leads to an increase in gut microbes that metabolize choline and subsequent development of hepatic steatosis in mice.(53) Manipulation of dietary intake of choline in human subjects resulted in variations in the abundance of Gammaproteobacteria and Erysipelotrichi, which were directly associated with t…”
Fonville, J. M., Richards, S. E., Barton, R. H., Boulangé, C. L., Ebbels, T. M. D., Nicholson, J. K., Holmes, E. C., & Dumas, M. (2010) · Journal of Chemometrics · doi:10.1002/cem.1359 · Cited by 180
“(in classification problems) include metabonomic parasitology [53–55], nutritional metabonomics [56,57], the genetics of metabolic profiles [56,58], metabonomic toxicology, cancer metabo-”
BackgroundSelf-citationNicoletti, A., Ponziani, F. R., Biolato, M., Valenza, V., Marrone, G., Sganga, G., Gasbarrini, A., Miele, L., & Grieco, A. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i33.4814 · Cited by 164
Non-alcoholic steatohepatitis: a microbiota-driven disease
Moschen, A. R., Kaser, S., & Tilg, H. (2013) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.05.009 · Cited by 170
In vivo imaging and genetic analysis link bacterial motility and symbiosis in the zebrafish gut
Rawls, J. F., Mahowald, M. A., Goodman, A. L., Trent, C. M., & Gordon, J. I. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702386104 · Cited by 159
Forcisi, S., Moritz, F., Kanawati, B., Tziotis, D., Lehmann, R., & Schmitt-Kopplin, P. (2013) · Journal of Chromatography A · doi:10.1016/j.chroma.2013.04.017 · Cited by 173
Nicholson, G., Rantalainen, M., Li, J. V., Maher, A. D., Malmodin, D., Ahmadi, K. R., Faber, J. H., Barrett, A., Min, J. L., Rayner, N. W., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002270 · Cited by 137
“Gut microbial activity has been linked to disease through physiological levels of DMA, TMA and TMAO [48–49].”
BackgroundSelf-citationDumas, M., Wilder, S. P., Bihoreau, M., Barton, R. H., Fearnside, J., Argoud, K., D’Amato, L., Wallis, R. H., Blancher, C., Keun, H. C., et al. (2007) · Nature Genetics · doi:10.1038/ng2026 · Cited by 151
“Here we demonstrate the impact of metabonomic-based QTL mapping on the study of the genetic basis of transgenomic effects, which are proposed to influence obesity and fatty liver in mic”
BackgroundSelf-citationJacobs, D., Gaudier, E., Duynhoven, J., & Vaughan, E. (2009) · Current Drug Metabolism · doi:10.2174/138920009787048383 · Cited by 157
“The conversion of choline into methylamines by microbiota in mice on a high-fat diet has been shown to reduce the bioavailability of choline and to mimic the effect of cholinedeficient diets, causing non-alcoholic fatty liver disease [164].”
BackgroundAnstee, Q. M., Concas, D., Kudo, H., Levene, A., Pollard, J., Charlton, P., Thomas, H. C., Thursz, M. R., & Goldin, R. D. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.03.016 · Cited by 158
“Animals started therapy after NAFLD/NASH had become established.”
InfluentialInvestigating Potential Mechanisms of Obesity by Metabolomics
Xie, B., Waters, M. J., & Schirra, H. J. (2012) · BioMed Research International · doi:10.1155/2012/805683 · Cited by 164
“proposed a diet-induced mechanism of steatosis, triggered by symbiotic microbiota, which mimic choline-deficient diets [12].”
BackgroundInfluentialHepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD
Reeves, H. L., Zaki, M. Y. W., & Day, C. P. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4085-6 · Cited by 166
Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk
Miele, L., Giorgio, V., Alberelli, M. A., De Candia, E., Gasbarrini, A., & Grieco, A. (2015) · Current Cardiology Reports · doi:10.1007/s11886-015-0671-z · Cited by 163
Gut microbiota, the pharmabiotics they produce and host health
Patterson, E., Cryan, J. F., Fitzgerald, G. F., Ross, R. P., Dinan, T. G., & Stanton, C. (2014) · Proceedings of the Nutrition Society · doi:10.1017/s0029665114001426 · Cited by 163
“Much like a choline-deficient diet, microbial metabolism of choline decreases the bioavailable levels of this essential nutrient and triggers nonalcoholic fatty liver disease((74)).”
BackgroundZhang, S., Nagana Gowda, G. A., Asiago, V., Shanaiah, N., Barbas, C., & Raftery, D. (2008) · Analytical Biochemistry · doi:10.1016/j.ab.2008.07.041 · Cited by 154
“Choline is degraded via (i) mammalian pathways in which choline is converted to creatinine via dimethylglycine and (ii) symxenobiotic pathways in which choline is converted to methylamine by gut microbiota [45].”
The gut microbiota and the metabolic health of the host
Joyce, S. A., & Gahan, C. G. M. (2014) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000039 · Cited by 147
“Notably, conversion of choline to trimethylamines by the microbiota has also been implicated in the causation of nonalcoholic fatty liver disease (NAFLD) in mice [72].”
BackgroundSun, L., Hu, W., Liu, Q., Hao, Q., Sun, B., Zhang, Q., Mao, S., Qiao, J., & Yan, X. (2012) · Journal of Proteome Research · doi:10.1021/pr3000317 · Cited by 152
Metadata
- Authors
- Dumas, M.-E., Barton, R. H., Toye, A., Cloarec, O., Blancher, C., Rothwell, A., Fearnside, J., Tatoud, R., Blanc, V., Lindon, J. C., Mitchell, S. C., Holmes, E., McCarthy, M. I., Scott, J., Gauguier, D., & Nicholson, J. K.
- Affiliations
- Imperial College London (GB)
- *Department of Biological Chemistry and
- Centre for Human Genetics (GB)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2006-08-15
- Volume
- 103
- Issue
- 33
- Pages
- 12511-12516
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1567909
- OpenAlex
- W2139464173
- Cited by
- 1,042
- References
- 0
- Citations by year
- 2026: 11 · 2025: 19 · 2024: 29 · 2023: 26 · 2022: 43 · 2021: 57 · 2020: 52 · 2019: 80 · 2018: 70 · 2017: 67 · 2016: 86 · 2015: 72 · 2014: 63 · 2013: 80 · 2012: 62
- FWCI
- 17.42
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust (057733, 066786)
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- gut microbiota, non-alcoholic fatty liver disease, insulin resistance, choline metabolism, phosphatidylcholine, trimethylamine N-oxide, methylamine, high-fat diet, impaired glucose homeostasis, metabotyping, host-microbe interactions, choline deficiency
- MeSH terms
- Animals, Body Weight, Dietary Fats, Fatty Liver, Glucose, Homeostasis, Insulin, Insulin Resistance, Lipids, Liver, Male, Methylamines, Mice, Inbred BALB C, Phenotype, Multivariate Analysis, Nuclear Magnetic Resonance, Biomolecular, Gastrointestinal Tract, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.